Mar 11, 2020
Big Pharma Partnering Terms & Agreements, Worldwide, 2014-2020 - Deal Trends, Key Players, Top Deal Values, Deal Financials
Mar 05, 2020
Worldwide Cancer Generics Industry Insights, 2018-2026: Comprehensive Insights on 43 Drugs & 29 Players
Feb 27, 2020
Hodgkin Lymphoma Treatment Market Forecasts to 2025 with Alkem Labs, Amneal Pharma, Baxter Int'l, Biogen, BMS, Roche, Incyte Corp, Merck & Co, Seattle Genetics, and Teva Pharma Industries Dominating
Dec 17, 2019
Drug Delivery Across Blood Brain Barrier Market Worth $4.6 Billion by 2026
Nov 11, 2019
Generics Markets, 2030 - Focus on Value-Added Medicines & Supergenerics
Jul 29, 2019
Alkermes Announces Settlement With Amneal Over VIVITROL® Patent Dispute
Jul 18, 2019
Biotech Brief: Acute Myeloid Leukemia Market to Reach $1.5 Billion Dollars by 2024
May 13, 2019
AMNEAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Amneal Pharmaceuticals, Inc. To Contact The Firm
Apr 02, 2019
Amneal Names Pradeep Bhadauria as Chief Scientific Officer
Apr 01, 2019
Amneal Announces Agreement with Zentiva to Divest Creo Pharma
Mar 06, 2019
Amneal Pharmaceuticals to Present at the Barclays Global Healthcare Conference
Feb 25, 2019
Visiongain Report Claims that 30% of the Top Generic Drug Producers are in the ROW Region
Jan 22, 2019
Amneal Names Accomplished Finance Executive Todd P. Branning As Chief Financial Officer
Jan 14, 2019
Amneal Announces Approval of Rivastigmine Transdermal System
Nov 21, 2018
Amneal to Present at the 30th Annual Piper Jaffray Healthcare Conference
Nov 12, 2018
Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine
Nov 12, 2018
Amneal Completes Transition Agreement With Lannett Company To Begin Commercialization Of Levothyroxine On December 1st
Nov 07, 2018
Myovant Strengthens Management Team and Adds New Directors to the Board
Oct 25, 2018
Expiration Dates for Certain Lots of Generic Adrenaclick® Epinephrine Injection, USP Auto-Injector Extended to 20 Months
Oct 24, 2018
Amneal Announces Issuance of New Patent for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa